Monoclonal antibodies and therapy of human cancers
- 31 August 2000
- journal article
- Published by Elsevier in Biotechnology Advances
- Vol. 18 (5), 385-401
- https://doi.org/10.1016/s0734-9750(00)00043-4
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Anticancer drug targets: growth factors and growth factor signalingJournal of Clinical Investigation, 2000
- Anticancer drug targets: approaching angiogenesisJournal of Clinical Investigation, 1999
- Pretargeting with the Affinity Enhancement System for RadioimmunotherapyCancer Biotherapy & Radiopharmaceuticals, 1999
- ImmunocytokinesPharmacology & Therapeutics, 1998
- Strategies for expressing human antibody repertoires in transgenic miceImmunology Today, 1996
- T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy.The Journal of Experimental Medicine, 1996
- Delivery of Molecular Medicine to Solid TumorsScience, 1996
- Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.Journal of Clinical Investigation, 1992
- Selection of phage antibodies by binding affinityJournal of Molecular Biology, 1992
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986